Original Air Date: May 26, 2020
Watch the on-demand webinar to learn advantages of DBcaps®, an over-encapsulation solution with a tamper-evident design that can address the clinical trial challenge of testing without bias.
Steve Rode, Business Development Manager,
Lonza Capsules & Health Ingredients
Stephen Rode, B.S, G.B.A. Currently, Steve is Manager of Business Development for Lonza’s Capsules and Health Ingredients group and is focused on supporting and growing the pipeline of new pharmaceutical and OTC products utilizing Lonza’s diverse portfolio of capsule-based products and technologies. Steve received his B.S. in Agronomy from Pennsylvania State University in 1980 and a G.B.A. in Executive Management from The Wharton School at the University of Pennsylvania in 1988.
With more than 31 years of industry experience, Steve has had the privilege of working with many top pharmaceutical and consumer healthcare companies in the development and launch of pivotal products. In addition to Steve’s sales and business development responsibilities, he has also had the opportunity to actively participate on various internal project teams associated with the development of DBcaps® capsules specifically for use in double-blind clinical trials, Vcaps® Plus HPMC capsules, and Coni-Snap® Sprinkle capsules for pediatric and geriatric drug delivery applications.
Julien Lamps, Product Manager
Lonza Capsules & Health Ingredients
Julien Lamps graduated from Ecole Nationale Supérieure de Chimie de Lille with an Engineering degree in Chemistry in 2004. Julien joined Capsugel as a Quality Assurance Engineer in the Colmar plant in 2011. In this role he worked at the interphase of Operations and Customers within the well-known Capsugel Quality Mindset. He specialized in coordinating new product introductions to develop innovative offers around modified release profiles and inhalation products.
He is now Product Manager for Lonza’s Capsules and Health Ingredients business unit focusing on Inhalation and HPMC portfolios.